Document is current
Any future updates will be listed below
-
Authors
Uchiyama, Kazuhiko https://orcid.org/0000-0001-5210-167X
Takagi, Tomohisa https://orcid.org/0000-0002-6119-4828
Mizushima, Katsura
Asaeda, Kohei
Kajiwara, Mariko
Kashiwagi, Saori
Minagawa, Yuki
Hotta, Yuma
Tanaka, Makoto
Inoue, Ken
Dohi, Osamu
Okayama, Tetsuya
Yoshida, Naohisa
Katada, Kazuhiro
Kamada, Kazuhiro
Ishikawa, Takeshi
Yasuda, Hiroaki
Konishi, Hideyuki
Kishimoto, Mitsuo
Naito, Yuji
Itoh, Yoshito
-
Funding
Funding for this research was provided by:
MAFF-commissioned project study on “Project for the realization of foods and dietary habits to extend healthy life expectancy” (JPJ009842)
Japan Society for the Promotion of Science (18K06224)
Japan Society for the Promotion of Science (20K08292)
Japan Society for the Promotion of Science (18766)
- License Information
-
More Information
Article History
Received: 7 November 2021
Accepted: 23 March 2022
First Online: 19 May 2022
Declarations
:
: KU received lecture fee from Mitsubishi Tanabe Pharma Corporation. TT received collaboration research funds from Sumitomo Seika Chemicals Co. Ltd. and received lecture fees from Mochida Pharma. Co. Ltd. and Yanssen Pharmaceutical K.K. YN received scholarship funds from EA Pharma. Co. Ltd., a collaboration research fund from Taiyo Kagaku Co., Ltd., and lecture fees from Mylan EPD Co., Takeda Pharma. Co., Ltd., Mochida Pharma. Co. Ltd., EA Pharma. Co. Ltd., Otsuka Pharma. Co. Ltd., and Miyarisan Pharma. Co. Ltd. This study was partly supported by these funds. YI received lecture fee from AbbVie GK, research fund from AbbVie G, Takeda Pharma. Co., Ltd., and EA Pharma. Co. Ltd. YN is an associate editor of “Digestion”. Neither the funding agency nor any outside organization participated in the study design or had any competing interests. These companies approved the final version of the manuscript.
: This study was judged by the Ethics Committee of the Kyoto Prefectural University of Medicine. The Ethics Committee of the Kyoto Prefectural University of Medicine approved the study protocol (approval number [ERB-C-610–4]) and also approved the written informed consent in the form of opt-out.
